TLRY Tilray Brands, Inc.

NEUTRAL Impact: 4/10 8-K
Horizon days Filed Apr 15, 2026 Processed 1mo ago SEC 0001140361-26-014692
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Latest settled — T+20d ⚠ clustered
TLRY ▼ -22.16% at T+20d
NEUTRAL call ✗ call lost -22.16% · α vs SPY -28.20% · entry $6.95 → $5.41
Next anchor: T+60d in 27d
Currently $4.98 · -28.35% from $6.95 entry
Entry anchored
Apr 14, 03:59 PM ET
via Databento tick
T+1d
-2.30%
call -2.30% · α -2.56%
$6.79
settled 8w ago
T+5d
+13.24%
call +13.24% · α +11.60%
$7.87
settled 7w ago
T+20d
-22.16%
call -22.16% · α -28.20%
$5.41
settled 4w ago
T+60d
call — · α —
in 27d

Price Chart

Loading chart...

Executive Summary

Tilray Brands entered into an at-the-market (ATM) equity offering program to sell up to $180 million in common stock through Jefferies, TD Securities, and Roth Capital Partners as agents. The company will use proceeds to support its global beverage platform expansion. This is a routine capital-raising mechanism with no immediate financial impact.

Key Financial Metrics

Deal Value
$180.0M

Actionable Insight

Monitor for actual share sales under this program, which could create near-term dilution. The 3% commission is standard for ATM programs. The proceeds allocation to beverage expansion suggests strategic focus on this segment.

Key Facts

  • Tilray Brands established an ATM equity program to sell up to $180 million in common stock
  • Jefferies, TD Securities, and Roth Capital Partners will act as sales agents
  • The company will pay agents a commission of up to 3% of gross proceeds
  • Proceeds will support expansion of the global beverage platform
  • The offering is subject to market conditions and there is no obligation to sell any shares

Financial Impact

Up to $180 million in potential equity issuance with 3% commission to agents

dilutioncash_flow

Risk Factors

  • Potential share dilution if the full $180 million is issued
  • Market perception of equity issuance as a negative signal

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-014692
Document: ny20066669x2_8k.htm0001140361-26-014692
Document: ny20066669x2_ex99-1.htm0001140361-26-014692
Document: ny20066669x2_ex5-1.htm0001140361-26-014692
Document: 0001140361-26-014692-index-headers.html0001140361-26-014692
Document: 0001140361-26-014692-index.html0001140361-26-014692
Document: 0001140361-26-014692.txt0001140361-26-014692
10 reports for TLRY
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +22.16%Apr 15, 2026
Filters
Rows
Reports for TLRY — sortable, filterable
Type Now
Apr 15, 2026
8w ago
424B5
BEARISH ★ 6/10
$6.95 $5.41▲ +22.16%▲ +28.20%$4.98 (+28.35%)
Apr 15, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$6.95 $5.41▼ −22.16%▼ −28.20%$4.98 (−28.35%)
Apr 15, 2026
8w ago
Press Release
MIXED ★ 6/10
$6.95 $5.41▼ −22.16%▼ −28.20%$4.98 (−28.35%)
Apr 1, 2026
10w ago
8-K
MIXED ★ 6/10
$6.14 $6.14· 0.00%▼ −9.72%$4.98 (−18.89%)
Apr 1, 2026
10w ago
Press Release
BULLISH ★ 7/10
$6.14 $6.14· 0.00%▼ −9.72%$4.98 (−18.89%)
Mar 26, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$6.54 $6.75▲ +3.21%▼ −7.45%$4.98 (−23.85%)
Mar 25, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$6.94 $6.94· 0.00%▼ −7.86%$4.98 (−28.24%)
Mar 16, 2026
12w ago
Press Release
BULLISH ★ 7/10
$6.90 $6.91▲ +0.14%▼ −3.63%$4.98 (−27.83%)
Mar 12, 2026
13w ago
Press Release
BULLISH ★ 7/10
$6.95 $6.57▼ −5.47%▼ −7.44%$4.98 (−28.35%)
Mar 2, 2026
14w ago
Press Release
BULLISH ★ 8/10
$7.60 $5.99▼ −21.18%▼ −13.25%$4.98 (−34.47%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (49h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access